Human health sciences: Multidisciplinary, general & others
Author, co-author :
Karnaushkina, M. A.; Department of Hospital Therapy No.2, I.M. Sechenov First Moscow State Medical University, 8/2 Trubetskaya St., Moscow, 119991, Russian Federation
Fedosenko, S. V.; Department of General Practice and Polyclinic Therapy, Siberian State Medical University, 2 Moskovsky trakt, Tomsk, 634050, Russian Federation
Sazonov, A. E.; Central Research Laboratory, Siberian State Medical University, 2 Moskovsky trakt, Tomsk, 634050, Russian Federation
Petrov, Viacheslav ; Siberian State Medical University (SSMU), 2, Moscow Trakt, Tomsk, 634050, Russian Federation
Ovsyannikov, D. Y.; Department of Pediatrics, Peoples’ Friendship University of Russia, 6 Miklukho-Maklaya St., Moscow, 117198, Russian Federation
Ogorodova, L. M.; Department of Pediatrics with the Course of Childhood Diseases, Faculty of Medicine, Siberian State Medical University, 2 Moskovsky trakt, Tomsk, 634050, Russian Federation
Language :
Russian
Title :
Microbiological oropharyngeal patterns in patients with different phenotypes of chronic obstructive pulmonary disease
Chuchalin A.G., Avdeev S.N., Aysanov Z.R., Belevskiy A.S., Leshchenko I.V., Meshcheryakova N.N., Ovcharenko S.I., Shmelev E.I. Russian respiratory society. Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. Russian Pulmonology 2014; 3: 15-36, https://doi.org/10.18093/0869-0189-2014-0-3-15-54.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD. Updated 2015.
Fedosenko S.V., Ogorodova L.M., Popenko A.S., Petrov V.A., Tyakht A.V., Saltykova I.V., Kamaltynova E.M., Deev I.A., Kulikov E.S., Kirillova N.A., Govorun V.M., Kostryukova E.S., Karnaushkina M.A. The qualitative and quantitative characteristics of content of oro-pharyngeal microbiota of patients with chronic obstructive disease of lungs. Lechenie i profilaktika 2015; 2(14): 92-99.
Avdeev S.N. Symptoms and quality of life in patients with chronic obstructive pulmonary disease: are there patientdefined outcomes or predictive factors? Russian Pulmonology 2016; 26(2): 231-237, https://doi.org/10.18093/0869-0189-2016-26-2-231-237.
Chambers D.C., Gellatly S.L., Hugenholtz P., Hansbro P.M. JTD special edition ‘Hot Topics in COPD’ — the microbiome in COPD. J Thorac Dis 2014; 6(11): 1525-1531, https://doi.org/10.3978/j.issn.2072-1439.2014.11.08.
Charlson E.S., Bittinger K., Haas A.R., Fitzgerald A.S., Frank I., Yadav A., Bushman F.D., Collman R.G. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 2011; 184: 957-963, https://doi.org/10.1164/rccm.201104-0655oc.
Górecka D., Puścińska E. Microbiome of the lung. Pneumonol Alergol Pol 2014; 82(6): 481-485, https://doi.org/10.5603/PiAP.2014.0063.
Park H., Shin J.W., Park S.G., Kim W. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease. PLoS One 2014; 9(10): e109710, https://doi.org/10.1371/journal.pone.0109710.
Molyneaux P.L., Mallia P., Cox M.J., Footitt J., Willis-Owen S.A., Homola D., Trujillo-Torralbo M.B., Elkin S., Kon O.M., Cookson W.O., Moffatt M.F., Johnston S.L. Outgrowth of the bacterial airway microbiome following rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 188(10): 1224-1231, https://doi.org/10.1164/rccm.201302-0341oc.
Patel A.R., Hurst J.R. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med 2011; 5(5): 647-662, https://doi.org/10.1586/ers.11.62.
Paulson J.N., Olson N.D., Wagner J., Talukder H., Pop M., Bravo H.C. Statistical analysis for sparse highthroughput sequencing, https://doi.org/10.18129/B9.bioc.metagenomeSeq.
Faust K., Sathirapongsasuti J.F., Izard J., Segata N., Gevers D., Raes J., Huttenhower C. Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol 2012; 8(7): e1002606, https://doi.org/10.1371/journal.pcbi.1002606.
Pragman A.A., Kim H.B., Reilly C.S., Wendt C., Isaacson R.E. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PloS One 2012; 7(10): e47305, https://doi.org/10.1371/journal.pone.0047305.
Sze M.A., Dimitriu P.A., Hayashi S., Elliott W.M., McDonough J.E., Gosselink J.V., Cooper J., Sin D.D., Mohn W.W., Hogg J.C. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185(10): 1073-1080, https://doi.org/10.1164/rccm.201111-2075oc.
Sin D., Sze M., Hogg J. Bacterial microbiome of lungs in COPD. Int J Chron Obstruct Pulmon Dis 2014; 9: 229-238, https://doi.org/10.2147/copd.s38932.
Ghannoum M.A., Jurevic R.J., Mukherjee P.K., Cui F., Sikaroodi M., Naqvi A., Gillevet P.M. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog 2010; 6(1): e1000713, https://doi.org/10.1371/journal.ppat.1000713.
Hsiao W.W., Li K.L., Liu Z., Jones C., Fraser-Liggett C.M., Fouad A.F. Microbial transformation from normal oral microbiota to acute endodontic infections. BMC Genomics 2012; 13: 345, https://doi.org/10.1186/1471-2164-13-345.
Pei Z., Yang L., Peek R.M., Jr Levine S.M., Pride D.T., Blaser M.J. Bacterial biota in reflux esophagitis and Barrett’s esophagus. World J Gastroenterol 2005; 11(46): 7277-7283, https://doi.org/10.3748/wjg.v11.i46.7277.
Sakae T.M., Pizzichini M.M., Teixeira P.J., Silva R.M., Trevisol D.J., Pizzichini E. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol 2013; 39(3): 259-271, https://doi.org/10.1590/s1806-37132013000300002.